🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "specific action to tackle cost of living pressures" in the upcoming Budget.

During an interview with the BBC, she stated that lowering price rises is a collective responsibility of both the administration and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

Sources suggest the government could intervene to lower energy bills, such as by slashing the current 5% level of value-added tax applied on energy supplies.

Another possibility is to cut some of the government charges presently added to household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such actions.

The consensus from most economists is that the Chancellor will have to declare higher taxes or expenditure reductions in order to meet her voluntary debt limits.

Earlier on the same day, calculations suggested there was a twenty-two billion pound deficit for the chancellor to address, which is at the more modest range of expectations.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the sources of price increases," Reeves told the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and Global Issues

While a great deal of the focus has been on probable tax rises, the Treasury chief said the most recent information from the OBR had not altered her commitment to election pledges not to increase rates on income tax, VAT or social security contributions.

She blamed an "uncertain world" with increasing international and trade concerns for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

International Trade Disputes

Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests invariably come first."

Recent declaration by China to strengthen trade restrictions on critical minerals and other materials that are crucial for high-technology manufacturing led US President the US President to threaten an further 100% tariff on imports from the Asian country, increasing the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called China's move "commercial pressure" and "a international production power grab."

Asked about accepting the US offer to join its battle with China, Reeves said she was "extremely troubled" by China's actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the world economy and generates further headwinds."

"It is my opinion there are fields where we need to confront Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other sectors of the economy. We've got to maintain that balance appropriate."

The chancellor also confirmed she was working with international partners "regarding our own critical minerals strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service spends on medicines could rise as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

Some of the biggest global drug companies have said recently that they are either delaying or abandoning operations in the United Kingdom, with several blaming the insufficient payments they are obtaining.

Recently, the Science Minister said the cost the health service pays for drugs would must increase to prevent firms and drug research funding departing from the UK.

Reeves stated to the BBC: "We have seen as a result of the cost structure, that drug testing, new drugs have not been available in the United Kingdom in the way that they are in other European countries."

"We want to make sure that patients receiving care from the National Health Service are can receive the top life-saving medicines in the world. And so we are reviewing all of that, and... looking to obtain more capital into Britain."